| Treadmill Cardiovascular Safety Study of Erenumab (AMG 334) (NCT02575833) | Amgen | 2015-11-23 |
| Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis (NCT02563899) | GlaxoSmithKline | 2015-11-23 |
| A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma (NCT02339571) | National Cancer Institute (NCI) | 2015-11-23 |
| Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies (NCT02608268) | Novartis Pharmaceuticals | 2015-11-23 |
| Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma (NCT02470091) | Children's Oncology Group | 2015-11-21 |
| LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC (NCT02494921) | Rahul Aggarwal | 2015-11-20 |
| 3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects (NCT03103295) | A.A. Partners, LLC | 2015-11-20 |
| Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates (NCT02564718) | Bayer | 2015-11-19 |
| Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies (NCT02579967) | National Cancer Institute (NCI) | 2015-11-19 |
| A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia (NCT02538965) | Celgene | 2015-11-19 |
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) (NCT02568267) | Hoffmann-La Roche | 2015-11-19 |
| Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery (NCT02607423) | ECOG-ACRIN Cancer Research Group | 2015-11-19 |
| Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U) (NCT04439331) | National Cancer Institute (NCI) | 2015-11-19 |
| The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease (NCT02546609) | NuSirt Biopharma | 2015-11-19 |
| A Gene Therapy Study for Hemophilia B (NCT02484092) | Pfizer | 2015-11-18 |
| A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) (NCT02553330) | Incyte Corporation | 2015-11-18 |
| Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4 (NCT02473146) | Versailles Hospital | 2015-11-18 |
| Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults (NCT02562482) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-11-18 |
| Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate (NCT02581839) | Case Comprehensive Cancer Center | 2015-11-17 |
| ASLAN001 in Patients With Advanced or Metastatic Cholangiocarcinoma Who Progressed on at Least 1 Line of Systemic Therapy (NCT02609958) | ASLAN Pharmaceuticals | 2015-11-16 |
| Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma (NCT02558894) | AstraZeneca | 2015-11-16 |
| 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer (NCT02624518) | Andrei Iagaru | 2015-11-16 |
| Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment Laryngeal Function (NCT02633540) | Fox Chase Cancer Center | 2015-11-16 |
| Probiotic Visbiome for Inflammation and Translocation in HIV Ι (NCT02441244) | University Health Network, Toronto | 2015-11-15 |
| Study of the Angiogenesis by PET/CT in Patients With Lymphoma (NCT02490891) | Centre Henri Becquerel | 2015-11-13 |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT02419469) | M.D. Anderson Cancer Center | 2015-11-13 |
| Effects of Transcranial Direct Current Stimulation (TDCS) in Drug-resistant Partial Epilepsy (NCT02465970) | Rennes University Hospital | 2015-11-13 |
| Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies (NCT02566304) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-11-13 |
| A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN) (NCT02550652) | Hoffmann-La Roche | 2015-11-13 |
| Dose-Escalation Study of ALXN1210 IV in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT02598583) | Alexion Pharmaceuticals, Inc. | 2015-11-12 |
| Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease (NCT02491359) | Fred Hutchinson Cancer Center | 2015-11-12 |
| A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860 (NCT02546960) | Janssen Research & Development, LLC | 2015-11-12 |
| SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma (NCT02303262) | Sarcoma Alliance for Research through Collaboration | 2015-11-12 |
| Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers (NCT03166423) | University of Chile | 2015-11-12 |
| Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma (NCT02535650) | Samsung Medical Center | 2015-11-12 |
| PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma (NCT02669511) | PIQUR Therapeutics AG | 2015-11-12 |
| Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC (NCT02473133) | Centre Henri Becquerel | 2015-11-12 |
| An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis (NCT02454205) | University of Cape Town | 2015-11-12 |
| Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy (NCT02595372) | Kathy Miller | 2015-11-12 |
| FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer (NCT02485834) | Alliance for Clinical Trials in Oncology | 2015-11-12 |
| Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer (NCT02500121) | Matthew Galsky | 2015-11-11 |
| Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC) (NCT02605486) | Memorial Sloan Kettering Cancer Center | 2015-11-11 |
| Effect of High-dose Naloxone Infusion on Pain and Hyperalgesia in Patients Following Groin-Hernia Repair. (NCT01992146) | Rigshospitalet, Denmark | 2015-11-11 |
| Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer (NCT02278185) | University of Colorado, Denver | 2015-11-11 |
| A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure) (NCT02483364) | Salvat | 2015-11-10 |
| Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD (NCT02464059) | University of North Carolina, Chapel Hill | 2015-11-10 |
| Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated (NCT02579382) | Gilead Sciences | 2015-11-10 |
| A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function (NCT02443155) | Novo Nordisk A/S | 2015-11-10 |
| Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL (NCT02557516) | Innate Pharma | 2015-11-09 |
| A Study to Assess the Efficacy and Safety of Enzalutamide in Subjects With Advanced Hepatocellular Carcinoma (NCT02528643) | Astellas Pharma Global Development, Inc. | 2015-11-09 |
| Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2) (NCT02601313) | Kite, A Gilead Company | 2015-11-09 |
| A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children (NCT02548078) | GlaxoSmithKline | 2015-11-09 |
| A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley) (NCT02554812) | Pfizer | 2015-11-09 |
| Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™ (NCT02582073) | Allergy Therapeutics | 2015-11-07 |
| Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies (NCT02358538) | Marinus Pharmaceuticals | 2015-11-06 |
| Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD (NCT03055247) | IRCCS San Raffaele | 2015-11-06 |
| Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults (NCT02564523) | Janssen Vaccines & Prevention B.V. | 2015-11-06 |
| Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma (NCT02584829) | Fred Hutchinson Cancer Center | 2015-11-06 |
| Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas (NCT02595424) | ECOG-ACRIN Cancer Research Group | 2015-11-06 |
| Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma (NCT02451111) | Swiss Cancer Institute | 2015-11-06 |
| Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02570165) | GlaxoSmithKline | 2015-11-06 |
| Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer. (NCT03606369) | Instituto Nacional de Cancerologia de Mexico | 2015-11-05 |
| Outcomes of Stem Cells for Cerebral Palsy (NCT02574923) | Vinmec Healthcare System | 2015-11-05 |
| PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors (NCT02584647) | Gulam Manji | 2015-11-04 |
| A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation (NCT02522299) | GlaxoSmithKline | 2015-11-04 |
| Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis (NCT02399410) | University Hospital, Ghent | 2015-11-04 |
| Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis (NCT02593123) | Virginia Commonwealth University | 2015-11-04 |
| Safety and Efficacy Study of LHW090 in Resistant Hypertension Patients (NCT02515331) | Novartis Pharmaceuticals | 2015-11-04 |
| A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma (NCT02529852) | M.D. Anderson Cancer Center | 2015-11-04 |
| Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC) (NCT02609048) | Gilead Sciences | 2015-11-04 |
| Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis (NCT02547922) | AstraZeneca | 2015-11-04 |
| PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB (NCT02412436) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-11-03 |
| Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT02420795) | M.D. Anderson Cancer Center | 2015-11-03 |
| A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC) (NCT02559570) | Forest Laboratories | 2015-11-03 |
| Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL (NCT02462538) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2015-11-03 |
| ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome (NCT02392572) | M.D. Anderson Cancer Center | 2015-11-03 |
| Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM) (NCT02357147) | Morphotek | 2015-11-03 |
| Investigating the Effects of Dietary Nitrate on Vascular Function, Platelet Reactivity and Restenosis in Stable Angina (NCT02529189) | Queen Mary University of London | 2015-11-02 |
| Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers (NCT02596711) | M.D. Anderson Cancer Center | 2015-11-02 |
| Study of Tremelimumab in Patients With Advanced Solid Tumors (NCT02527434) | AstraZeneca | 2015-11-02 |
| CD34+ Selected ASCT for Aggressive Lymphomas (NCT02646098) | Insel Gruppe AG, University Hospital Bern | 2015-11-02 |
| Effects of Inhibiting Early Inflammation in Kidney Transplant Patients (NCT02495077) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-11-02 |
| The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation (NCT02831894) | National Jewish Health | 2015-11-02 |
| Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer (NCT02540356) | Baxalta now part of Shire | 2015-11-02 |
| Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses (NCT03620032) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-11-02 |
| Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy (NCT02638467) | University of Milano Bicocca | 2015-11-01 |
| Zero Ischemia Laparoscopic Partial Nephrectomy (NCT02634385) | St. Joseph's Healthcare Hamilton | 2015-11-01 |
| A Study on the Efficacy of Glucosamine Sulfate Potassium Chloride/Standardized Ginkgo Biloba Leaf Extract in Adults With Osteoarthritis of the Knee. (NCT02604381) | KGK Science Inc. | 2015-11-01 |
| Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease (NCT02912169) | Ageless Regenerative Institute | 2015-11-01 |
| Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) (NCT02605616) | University of Alabama at Birmingham | 2015-11-01 |
| Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer (NCT02841228) | Hunan Province Tumor Hospital | 2015-11-01 |
| Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled LPS (NCT02104505) | University of North Carolina, Chapel Hill | 2015-11-01 |
| Endostar for Locally Recurrent Nasopharyngeal Carcinoma (NCT02636231) | Sun Yat-sen University | 2015-11-01 |
| DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization (NCT02146664) | Dexa Medica Group | 2015-11-01 |
| The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma (NCT01953406) | Seoul National University Hospital | 2015-11-01 |
| Effect of Spinal Dexamethasone During Transuretheral Prostatectomy (NCT02619019) | Assiut University | 2015-11-01 |
| Clinical Study of Biocellulose Wound Dressing Containing Silk Sericin and PHMB for STSG Donor Sites (NCT02643680) | Chulalongkorn University | 2015-11-01 |
| Effect of Enhanced Counseling Using Complementary Feeding Recommendation Based on Linear Programming on Nutritional Status,Omega-3 Fatty Acids, Malondialdehyde, and Alpha-Tocopherol in Overweight Children in East Jakarta (NCT02592109) | Indonesia University | 2015-11-01 |
| Regorafenib in Relapsed Glioblastoma (NCT02926222) | Istituto Oncologico Veneto IRCCS | 2015-11-01 |
| Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP) (NCT02512653) | Laboratorios Leti, S.L. | 2015-11-01 |